Large-scale testing (Phase 3)Ended earlyNCT04115839
What this trial is testing
Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy
Who this might be right for
Psoriatic Arthritis
Gilead Sciences 106